Company / PP&E per Share
Vertex Pharmaceuticals PP&E per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$2.97
FY2019
5-year range
-
FY2016-FY2019
Trend
-7.3%
vs FY2018
Sector context
#30 of 191
Health Care
What the data says
Vertex Pharmaceuticals's pp&e per share of $2.97 is higher than 84% of companies in the Health Care sector (FY2019). Declined from $3.18 to $2.97 over the past 2 years.
Based on SEC 10-K filings.
2.97 in FY2019 with a 3-year CAGR of +1.6%. Top quartile in the Health Care sector.
Declined from $3.18 to $2.97 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 191This company $2.97 Sector average $22.34
▼
-86.7% below sector average
Key checks
Key Insights
- In FY2019, pp&e per share decreased 7.3% year-over-year.
- Ranks #30 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $2.97 | -7.3% |
| FY2018 | $3.21 | +0.8% |
| FY2017 | $3.18 | +12.1% |
| FY2016 | $2.84 | -1.8% |
As of FY2019 · SEC 10-K · Updated Mar 17, 2026